Tribune News Service
New Delhi, October 3
Even as the Covid toll in India this morning breached the one lakh-mark and cases climbed to 64,73,544, the country posted the largest share of 21 per cent in global recoveries while its share in the world caseload came to 18.6 per cent.
The toll reached 1,00,842 with 1,069 deaths in 24 hours. There were 79,476 new infections and 75,628 recoveries.
India accounted for 21 per cent of global recoveries while its share in the total cases stood at 18.6 per cent, the Health Ministry said. The US accounts for 21.7 per cent of global cases and 18.4 per cent recoveries.
“India has also maintained one of the lowest case fatality rates (CFR) globally. While the global CFR is 2.97 per cent, India’s CFR is 1.56 per cent. The deaths per million in India are one of the lowest in the world at 73 against 130 globally,” the ministry said. The CFR in the US is 2.87 per cent and in the UK it is a whopping 9.17 per cent.
Meanwhile, Hyderabad-based Dr Reddy’s Laboratories today applied to Drugs Controller General of India for approval to start phase-3 human clinical trials of Sputnik V, the Russian Covid vaccine, in India. Dr Reddy’s recently struck a deal with the Russian Direct Investment Fund for supply of 100 million doses of the vaccine in India, upon regulatory permissions.